Summary
This Form 8-K filing from WellPoint, Inc. (which later became Elevance Health) on September 12, 2011, primarily serves as a Regulation FD disclosure. The company announced that its officers would be speaking with securities analysts and investors between September 13 and September 26, 2011. During these interactions, WellPoint intended to reaffirm its full-year 2011 earnings per share (EPS) guidance, projecting a range of $6.90 to $7.10 per share. This guidance included an estimated $0.15 per share from net investment gains and did not account for any additional investment gains or losses beyond those already recognized in the first two quarters of the fiscal year. The filing also contains a standard "safe harbor" statement under the Private Securities Litigation Reform Act of 1995. This statement outlines the forward-looking nature of certain statements made by the company and the inherent risks and uncertainties that could cause actual results to differ materially from projections. Investors should note that the information provided here is for disclosure purposes and is not considered "filed" under Section 18 of the Securities Exchange Act, meaning it does not carry the same legal implications as a filed report.
Key Highlights
- 1WellPoint reaffirmed its full-year 2011 EPS guidance of $6.90 to $7.10 per share.
- 2The EPS guidance includes an expected $0.15 per share from net investment gains.
- 3No new investment gains or losses beyond Q1 and Q2 2011 are included in the guidance.
- 4The company's officers are scheduled to discuss these matters with analysts and investors from September 13 to September 26, 2011.
- 5The filing includes a safe harbor statement related to forward-looking statements and associated risks.
- 6Information furnished in this 8-K is not deemed 'filed' for Section 18 purposes.